Correspondence 0001104659-23-130005 from Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Date: Dec. 28, 2023 · CIK: 0001454789 · Accession: 0001104659-23-130005
AI Filing Summary & Sentiment
File numbers found in text: 333-276057
Show Raw Text
CORRESP
1
filename1.htm
ASTRIA THERAPEUTICS, INC.
75 State Street
Suite 1400
Boston, Massachusetts 02109
December 28, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Astria Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-276057
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under
the Securities Act of 1933, as amended, Astria Therapeutics, Inc. (the “Registrant”) hereby requests
acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-276057), so that it may become
effective at 4:30 p.m. Eastern time on December 29, 2023, or as soon thereafter as practicable, or at such later time
as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
ASTRIA THERAPEUTICS, INC.
By:
/s/ Ben Harshbarger
Name:
Ben Harshbarger
Title:
Chief Legal Officer and Corporate Secretary
cc:
Rosemary G. Reilly, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP